First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait
Affiliations
Affiliations
- Mycology Laboratory, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait, khaled22m@live.com.
- Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
- Microbiology Unit, Medical Laboratory Department, Sabah Hospital, Shuwaikh, Kuwait.
Abstract
Objective: C. nivariensis is a rare Candida species which is phenotypically closely related to Candida glabrata and Candida bracarensis. The 3 species form the C. glabrata sensu lato complex. Here, we describe the first isolation and characterization of a C. nivariensis isolate cultured from the tracheal aspirate obtained from a young man in Kuwait.
Materials and methods: The yeast isolate was initially tested by VITEK 2 followed by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and multiplex PCR. The identification was confirmed by sequencing of internal transcribed spacer (ITS) region of rDNA. Antifungal susceptibility testing was performed by Etest, and phylogenetic comparison with other international strains was carried out by using MEGA version 7 software.
Results: The C. nivariensis isolate was misidentified by VITEK 2, but correctly identified by MALDI-TOF MS with updated software and multiplex PCR. The identity was confirmed by sequence comparisons of ITS region of rDNA. Antifungal susceptibility testing revealed high minimum inhibitory concentration (MIC) against fluconazole, but low MICs against amphotericin B and echinocandins. Phylogenetically, our isolate was closely related to Indian isolates.
Conclusions: This report extends the geographic distribution of C. nivariensis to the Arabian Peninsula. MALDI-TOF MS with updated software and molecular tests are needed to correctly identify C. nivariensis. Since C. nivariensis may exhibit reduced susceptibility to antifungal agents, accurate identification and antifungal susceptibility testing are essential, particularly for isolates from sterile sites, for optimal patient management.
Keywords: Antifungal resistance; Candida nivariensis; Kuwait; Matrix-assisted laser desorption ionization-time of flight mass spectrometry; Rare yeasts.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
Hou X, Xiao M, Chen SC, Wang H, Yu SY, Fan X, Kong F, Xu YC.Front Microbiol. 2017 Jan 19;8:5. doi: 10.3389/fmicb.2017.00005. eCollection 2017.PMID: 28154553 Free PMC article.
Arastehfar A, Daneshnia F, Salehi MR, Zarrinfar H, Khodavaisy S, Haas PJ, Roudbary M, Najafzadeh MJ, Zomorodian K, Charsizadeh A, Brouwer C, Pan W, Hagen F, Boekhout T.J Med Microbiol. 2019 May;68(5):770-777. doi: 10.1099/jmm.0.000963. Epub 2019 Mar 29.PMID: 30924763 Review.
Sikora M, Kuthan R, Piskorska-Malolepsza K, Golas-Pradzynska M, Domański D, Augustynowicz-Kopeć E, Swoboda-Kopec E.Pol J Microbiol. 2019 Sep;68(3):303-308. doi: 10.33073/pjm-2019-032. Epub 2019 Sep 3.PMID: 31880875 Free PMC article.
Asadzadeh M, Alanazi AF, Ahmad S, Al-Sweih N, Khan Z.PLoS One. 2019 Oct 16;14(10):e0223920. doi: 10.1371/journal.pone.0223920. eCollection 2019.PMID: 31618264 Free PMC article.
Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC.Dan Med J. 2013 Nov;60(11):B4698.PMID: 24192246 Review.
Cited by
Treatment of Candida nivariensis Blood Stream Infection With Oral Isavuconazole.
Randazza O, Erickson K, Denmeade T, Luther V, Palavecino E, Beardsley J.Cureus. 2022 Dec 2;14(12):e32137. doi: 10.7759/cureus.32137. eCollection 2022 Dec.PMID: 36601144 Free PMC article.
Chamroensakchai T, Sanaklang N, Hurdeal VG, Banjongjit A, Hyde KD, Kanjanabuch T.Med Mycol Case Rep. 2022 Dec 5;39:5-7. doi: 10.1016/j.mmcr.2022.11.002. eCollection 2023 Mar.PMID: 36568645 Free PMC article.
Hernando-Ortiz A, Eraso E, Quindós G, Mateo E.J Fungi (Basel). 2021 Nov 23;7(12):998. doi: 10.3390/jof7120998.PMID: 34946981 Free PMC article.